1. Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial. Issue 6 (June 2020) Authors: Shu, Catherine A; Gainor, Justin F; Awad, Mark M; Chiuzan, Codruta; Grigg, Claud M; Pabani, Aliyah; Garofano, Robert F; Stoopler, Mark B; Cheng, Simon K; White, Abby; Lanuti, Michael; D'Ovidio, Frank; Bacchetta, Matthew; Sonett, Joshua R; Saqi, Anjali; Rizvi, Naiyer A Journal: Lancet oncology Issue: Volume 21:Issue 6(2020) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma. (August 2020) Authors: Baldacci, Simon; Grégoire, Valérie; Patrucco, Enrico; Chiarle, Roberto; Jamme, Philippe; Wasielewski, Eric; Descarpentries, Clotilde; Copin, Marie-Christine; Awad, Mark M; Cortot, Alexis B Journal: Lung cancer Issue: Volume 146(2020) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. Issue 2 (16th February 2022) Authors: Cortellini, Alessio; Ricciuti, Biagio; Vaz, Victor R; Soldato, Davide; Alessi, Joao V; Dall'Olio, Filippo G; Banna, Giuseppe L; Muthuramalingam, Sethupathi; Chan, Samuel; Majem, Margarita; Piedra, Aida; Lamberti, Giuseppe; Andrini, Elisa; Addeo, Alfredo; Friedlaender, Alex; Facchinetti, Francesco... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Response to Hopkins, Kichenadasse, Logan, et al. (27th August 2021) Authors: Wang, Xinan; Ricciuti, Biagio; Alessi, Joao V; Nguyen, Tom; Awad, Mark M; Lin, Xihong; Johnson, Bruce E; Christiani, David C Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 3(2022) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial. Issue 2 (February 2022) Authors: Schoenfeld, Jonathan D; Giobbie-Hurder, Anita; Ranasinghe, Srinika; Kao, Katrina Z; Lako, Ana; Tsuji, Junko; Liu, Yang; Brennick, Ryan C; Gentzler, Ryan D; Lee, Carrie; Hubbard, Joleen; Arnold, Susanne M; Abbruzzese, James L; Jabbour, Salma K; Uboha, Nataliya V; Stephans, Kevin L; Johnson, Jennif... Journal: Lancet oncology Issue: Volume 23:Issue 2(2022) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC. Issue 2 (5th October 2020) Authors: Keegan, Alissa; Ricciuti, Biagio; Garden, Padric; Cohen, Limor; Nishihara, Reiko; Adeni, Anika; Paweletz, Cloud; Supplee, Julianna; Jänne, Pasi A; Severgnini, Mariano; Awad, Mark M; Walt, David R Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC. Issue 2 (5th October 2020) Authors: Keegan, Alissa; Ricciuti, Biagio; Garden, Padric; Cohen, Limor; Nishihara, Reiko; Adeni, Anika; Paweletz, Cloud; Supplee, Julianna; Jänne, Pasi A; Severgnini, Mariano; Awad, Mark M; Walt, David R Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC. Issue 2 (5th October 2020) Authors: Keegan, Alissa; Ricciuti, Biagio; Garden, Padric; Cohen, Limor; Nishihara, Reiko; Adeni, Anika; Paweletz, Cloud; Supplee, Julianna; Jänne, Pasi A; Severgnini, Mariano; Awad, Mark M; Walt, David R Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC. Issue 2 (5th October 2020) Authors: Keegan, Alissa; Ricciuti, Biagio; Garden, Padric; Cohen, Limor; Nishihara, Reiko; Adeni, Anika; Paweletz, Cloud; Supplee, Julianna; Jänne, Pasi A; Severgnini, Mariano; Awad, Mark M; Walt, David R Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer. (11th June 2021) Authors: Wang, Xinan; Ricciuti, Biagio; Alessi, Joao V; Nguyen, Tom; Awad, Mark M; Lin, Xihong; Johnson, Bruce E; Christiani, David C Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 12(2021) Page Start: 1761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗